Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.
2.

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.

Miner PB Jr, Wedel MK, Xia S, Baker BF.

Aliment Pharmacol Ther. 2006 May 15;23(10):1403-13. Erratum in: Aliment Pharmacol Ther. 2006 Oct 15;24(8):1268.

3.

A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.

van Deventer SJ, Wedel MK, Baker BF, Xia S, Chuang E, Miner PB Jr.

Aliment Pharmacol Ther. 2006 May 15;23(10):1415-25.

4.
5.

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.

Miner PB Jr, Geary RS, Matson J, Chuang E, Xia S, Baker BF, Wedel MK.

Aliment Pharmacol Ther. 2006 May 15;23(10):1427-34.

6.

Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis.

Vegter S, Tolley K, Wilson Waterworth T, Jones H, Jones S, Jewell D.

Aliment Pharmacol Ther. 2013 Aug;38(3):284-93. doi: 10.1111/apt.12369. Epub 2013 Jun 10.

7.

Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.

Yacyshyn BR, Barish C, Goff J, Dalke D, Gaspari M, Yu R, Tami J, Dorr FA, Sewell KL.

Aliment Pharmacol Ther. 2002 Oct;16(10):1761-70.

8.

Alicaforsen. Isis Pharmaceuticals.

Gewirtz AT, Sitaraman S.

Curr Opin Investig Drugs. 2001 Oct;2(10):1401-6. Review.

PMID:
11890355
9.

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.

Yacyshyn BR, Chey WY, Goff J, Salzberg B, Baerg R, Buchman AL, Tami J, Yu R, Gibiansky E, Shanahan WR; ISIS 2302-CS9 Investigators.

Gut. 2002 Jul;51(1):30-6.

10.

Technology evaluation: alicaforsen (Isis).

Gewirtz AT, Sitaraman SV.

Curr Opin Mol Ther. 2005 Jun;7(3):273-81. Review.

PMID:
15977426
11.
12.
13.

Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study.

Pokrotnieks J, Marlicz K, Paradowski L, Margus B, Zaborowski P, Greinwald R.

Aliment Pharmacol Ther. 2000 Sep;14(9):1191-8.

14.
15.

A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.

Kam L, Cohen H, Dooley C, Rubin P, Orchard J.

Am J Gastroenterol. 1996 Jul;91(7):1338-42.

PMID:
8677990
16.

Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.

Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'IncĂ  R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F.

Dig Liver Dis. 2007 Apr;39(4):329-37. Epub 2007 Mar 7.

PMID:
17347061
17.

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.

Reinisch W, Sandborn WJ, Hommes DW, D'Haens G, Hanauer S, Schreiber S, Panaccione R, Fedorak RN, Tighe MB, Huang B, Kampman W, Lazar A, Thakkar R.

Gut. 2011 Jun;60(6):780-7. doi: 10.1136/gut.2010.221127. Epub 2011 Jan 5.

PMID:
21209123
18.

Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.

Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP.

Am J Gastroenterol. 2009 Jun;104(6):1452-9. doi: 10.1038/ajg.2009.83. Epub 2009 Apr 21.

PMID:
19491859
20.

A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.

Safdi M, DeMicco M, Sninsky C, Banks P, Wruble L, Deren J, Koval G, Nichols T, Targan S, Fleishman C, Wiita B.

Am J Gastroenterol. 1997 Oct;92(10):1867-71.

PMID:
9382054

Supplemental Content

Support Center